Pakistan's Drug Regulatory Authority Dismisses Reports of Essential Medicine Price Hikes Amid Surges in Rawalpindi
While Rawalpindi has seen drug prices surge by up to 500%, Pakistan's Drug Regulatory Authority (Drap) has dismissed national reports of essential medicine price hikes, stating rates have not undergone upward revision.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (19/100)Sources
Drap dismisses reports of essential medicine price hikes amid global supply chain uncertainty
The Drug Regulatory Authority of Pakistan (Drap) on Sunday dismissed reports of price hikes in essential medicines across the country, stating that the rates have not “undergone any upward revision”. The statement comes as stakeholders in recent news reports alleged that an unprecedented increase in medicine prices had been observed since February 2024. Pakistan Drug Lawyers Forum President Noor Muhammad Mehr, a day earlier, told Dawn that the price of the insulin delivery device HumaPen Ergo...
By none@none.com (Umaid Ali)
Read full article →Drug prices surge up to 500% in Pindi
Insulin devices jump from Rs2,200 to Rs4,720; Bohar Bazaar sees major price hike
By Qaiser Shirazi
Read full article →Coverage Timeline
Related Stories
Arkia Cancels Jordan Flights Amid Approval Issues
just now
Philippine Lawmaker Urges Government to Build Coastal Petroleum Storage Facilities
just now
DICT Pledges Wider Free Internet Access on Philippines' 32nd Connectivity Anniversary
just now
Philippine SSS Considers Loan Relief and Condonation Programs
just now